Post-Ureteroscopy Infections Are Linked to Pre-Operative Stent Dwell Time over Two Months: Outcomes of Three European Endourology Centres
Overview
Authors
Affiliations
Background: The aim of this study is to investigate outcomes of pre-operative stent dwell time on infectious complications following ureteroscopy and stone treatment to identify a time cut-off.
Material And Methods: Three tertiary referral centres in Europe retrospectively collected outcomes of ureteroscopy and laser fragmentation (URSL) for all patients with pre-operative indwelling ureteric stents over a period of up to 5 years. Data was collected on patient details, stone demographics, stent dwell time, complications and stone free rate (SFR). Matching for age, sex, operative time, stone size and post-operative stent insertion. To examine for a threshold effect, monthly cut-offs were used to compare post-ureteroscopic febrile UTIs. Binomial logistic regression was used (SPSS v.24) with a significance level set at 0.0036. The risk ratio (RR) with a 95% confidence interval (CI) and the number needed to harm (NNH) are reported.
Results: There were 467 patients with a pre-operative stent for analysis. These patients ( = 315) were matched to non-stented controls after excluding 152 patients to achieve adequate matching. There was a significant difference in rates of post-ureteroscopic febrile UTI between stented vs non-stented patients (RR = 2.67, 95% CI: 1.10-6.48, = 0.03). On adjustment, a dwell time of more than two months was associated with an increased risk of post-ureteroscopic febrile UTI (RR = 3.94, 95% CI: 1.30-12.01, = 0.02), this increased risk rose with longer dwell time. At stent time longer than four months was associated with a significantly increased risk of post-ureteroscopic febrile UTI (5% vs. 15%, RR = 3.09, 95% CI: 1.56-6.10, = 0.001), with the number needed to harm at 10.
Conclusions: Overall infectious complication rates from URSL are low. The risk of post-operative UTI after four months of dwell time is nearly tripled compared to less than four months.
Pattou M, Yonneau L, de Gouvello A, Almeras C, Saussine C, Hoznek A World J Urol. 2024; 42(1):534.
PMID: 39306607 DOI: 10.1007/s00345-024-05251-3.
Nedbal C, Adithya S, Naik N, Gite S, Juliebo-Jones P, Somani B Eur Urol Open Sci. 2024; 64:30-37.
PMID: 38832122 PMC: 11145425. DOI: 10.1016/j.euros.2024.05.004.
Bhatnagar D, Nedbal C, Somani B Arab J Urol. 2024; 22(3):171-178.
PMID: 38818254 PMC: 11136461. DOI: 10.1080/20905998.2024.2320028.
Batura D, Elsweefy M, Chouhan R, Bassett P, Gopal Rao G World J Urol. 2024; 42(1):196.
PMID: 38530494 DOI: 10.1007/s00345-024-04900-x.
Damavand R, Esmaeili S, Bateni B, Tavakoli A, Kazemnezhad E World J Urol. 2023; 41(11):3027-3032.
PMID: 37775547 DOI: 10.1007/s00345-023-04585-8.